Annual report pursuant to Section 13 and 15(d)

Selected Quarterly Financial Data (unaudited) (Tables)

v3.6.0.2
Selected Quarterly Financial Data (unaudited) (Tables)
12 Months Ended
Dec. 31, 2016
Selected Quarterly Financial Data (unaudited)  
Schedule of selected quarterly financial information

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

    

March 31, 2016

    

June 30, 2016

    

September 30, 2016

    

December 31, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

 —

 

$

 —

 

$

 —

 

$

317

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

8,265

 

 

9,525

 

 

11,584

 

 

8,443

 

General and administrative

 

 

2,371

 

 

2,540

 

 

2,633

 

 

2,919

 

Total operating expenses

 

 

10,636

 

 

12,065

 

 

14,217

 

 

11,362

 

Loss from operations

 

 

(10,636)

 

 

(12,065)

 

 

(14,217)

 

 

(11,045)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income, net

 

 

48

 

 

44

 

 

48

 

 

80

 

Net loss

 

$

(10,588)

 

$

(12,021)

 

$

(14,169)

 

$

(10,965)

 

Accrued dividends on preferred stock

 

 

(1,737)

 

 

(1,823)

 

 

(121)

 

 

 —

 

Net loss applicable to common stockholders

 

$

(12,325)

 

$

(13,844)

 

$

(14,290)

 

$

(10,965)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share applicable to common stockholders - basic and diluted

 

$

(5.15)

 

$

(5.42)

 

$

(0.65)

 

$

(0.47)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted

 

 

2,394,470

 

 

2,553,146

 

 

22,012,743

 

 

23,374,734

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

    

March 31, 2015

    

June 30, 2015

    

September 30, 2015

    

December 31, 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

 —

 

$

317

 

$

 —

 

$

 —

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

3,736

 

 

5,428

 

 

6,866

 

 

8,378

 

General and administrative

 

 

836

 

 

984

 

 

1,598

 

 

2,311

 

Total operating expenses

 

 

4,572

 

 

6,412

 

 

8,464

 

 

10,689

 

Loss from operations

 

 

(4,572)

 

 

(6,095)

 

 

(8,464)

 

 

(10,689)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense), net

 

 

4

 

 

(2)

 

 

 —

 

 

 —

 

Net loss

 

$

(4,568)

 

$

(6,097)

 

$

(8,464)

 

$

(10,689)

 

Accrued dividends on preferred stock

 

 

(1,217)

 

 

(1,230)

 

 

(1,243)

 

 

(1,244)

 

Net loss applicable to common stockholders

 

$

(5,785)

 

$

(7,327)

 

$

(9,707)

 

$

(11,933)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share applicable to common stockholders - basic and diluted

 

$

(3.44)

 

$

(4.16)

 

$

(4.51)

 

$

(5.14)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted

 

 

1,682,690

 

 

1,761,457

 

 

2,150,274

 

 

2,320,781